Brown Advisory Inc Vericel Corp Transaction History

Brown Advisory Inc

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 May 15, 2020	SELL	$7.25 - $19.22 $126,708 - $335,907	-17,477 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$13.77 - $19.2 $240,658 - $335,558	17,477 New	17,477 $303,000
Q2 2019 Aug 12, 2019	SELL	$15.01 - $18.89 $155,023 - $195,095	-10,328 Closed	0 $0
Q1 2019 May 15, 2019	BUY	$16.23 - $20.29 $167,623 - $209,555	10,328 New	10,328 $182,000
Q3 2018 Nov 13, 2018	SELL	$9.1 - $14.8 $91,746 - $149,213	-10,082 Closed	0 $0
Q2 2018 Aug 10, 2018	BUY	$9.6 - $14.6 $96,787 - $147,197	10,082 New	10,082 $98,000

275

48.4M

91.8K

23.2K

Ticker VCEL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 47,178,000
Market Cap $2.76B
Description
Vericel Corporation, a commercial-stage biopharmaceutical company, engages in the research, development, manufacture, and distribution of cellular therapies for sports medicine and severe burn care markets in the United States. The company markets autologous cell therapy products comprising MACI, an autologous cellularized scaffold product for t...

Get notified when there are updates to the investment portfolio of Brown Advisory Inc, based on Form 13F filings with the SEC.

Stay updated on Brown Advisory Inc with notifications on news.